transpupillary thermotherapy


Also found in: Acronyms, Encyclopedia.

transpupillary thermotherapy

, transpupillary thermal therapy,

TTT

The use of an infrared laser to elevate the temperature of the retinal pigment epithelium to treat retinal diseases such as melanomas of the choroid, retinoblastoma, or the wet form of macular degeneration.
Mentioned in ?
References in periodicals archive ?
Transpupillary thermotherapy of predominantly occult choroidal neovascularization in age-related macular degeneration with 12 months follow-up.
Boutacoff added, "we expect to see increased sales of our infrared product line due to the recent announcement of Noridian, a Medicare carrier that covers 11 western states, that it is now covering transpupillary thermotherapy (TTT) procedures to treat wet AMD.
IRIDEX Corporation (Nasdaq:IRIX) announced today that Noridian Mutual Insurance, a Medicare Part B Carrier, published that it will begin to cover transpupillary thermotherapy (TTT) procedures administered to treat choroidal neovascularization (CNV) secondary to wet age-related macular degeneration (AMD) effective for dates of service on or after May 1, 2001.
During the second half of 2000, the Health Care Financing Administration (HCFA) deferred reimbursement decisions for Transpupillary Thermotherapy (TTT) and other AMD procedures to the discretion of the medical directors for the local Medicare carriers.
30, 2001--IRIDEX Corporation (NASDAQ/NMS:IRIX) announced positive results from a recently published study(1) performed at King's College Hospital in London, England using an IRIDEX OcuLight(R) laser to assess the efficacy of transpupillary thermotherapy (TTT) photocoagulation for the treatment of choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD).
IRIDEX Corporation (NASDAQ/NMS:IRIX) announced that results from two clinical studies, one performed in Japan and a second performed in the USA, provide additional validation of successful outcomes following Transpupillary Thermotherapy (TTT) treatment of subfoveal occult wet age-related macular degeneration (AMD).
Boutacoff, "several new studies on the use of transpupillary thermotherapy (TTT) photocoagulation for the treatment of occult subfoveal wet AMD were presented during the quarter.